1. Re: Twenty-Year Follow-Up in Patients with Aplastic Anemia Given Marrow Grafts from HLA-Identical Siblings and Randomized to Receive Methotrexate/Cyclosporine or Methotrexate Alone for Prevention of Graft-versus-Host Disease 
Mohamed L. Sorror, MD, Wendy Leisenring, ScD, H. Joachim Deeg, MD, Paul J. Martin, MD, Rainer Storb, MD 
Biology of Blood and Marrow Transplantation 
Volume 11, Issue 7, Pages (July 2005)
DOI: /j.bbmt
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
A, Kaplan-Meier product estimates for overall survival. B, Prevalence [3] of chronic GVHD among patients with aplastic anemia who were administered marrow grafts from HLA-identical siblings with either methotrexate/cyclosporine (MTX + CSP) or methotrexate alone (MTX) for GVHD prophylaxis.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2005 American Society for Blood and Marrow Transplantation Terms and Conditions